Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

Related Keywords

South Africa ,United States ,India , ,Yale University ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Ntibody ,B Cell ,Flood ,D4 ,Fell ,Coronavirus ,Ytometry ,Efficacy ,Flow Cytometry ,Genes ,Immune Response ,Immunity ,Immunization ,Interferon ,Interferon Gamma ,Lymph Node ,Anoparticle ,Protein ,Pseudovirus ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spleen ,Yndrome ,Transcriptomics ,Vaccine ,Virus ,